Mualliflar

  • Yodgorova N.T., Abdumannobov A.A., Elmo'minova R.S., Xudoyberdiyeva M.Sh.

##semicolon##

klebsiella pneumoniae, antibiotiklarga chidamlilik, karbapenemga chidamlilik, bakteriemiya, siydik yo‘llari infeksiyasi, virulentlik, bakteriofag terapiyasi.

##submission.citations##

1. Bulman ZP, Krapp F, Pincus NB, Wenzler E, Murphy KR, Qi C, Ozer EA, Hauser AR. Genomic Features Associated with the Degree of Phenotypic Resistance to Carbape-nems in Carbapenem-Resistant Klebsiella pneumoniae. mSystems. 2021 Oct 26; 6(5): e0019421. doi: 10.1128/mSys¬tems.00194-21. Epub 2021 Sep 14. PMID: 34519526; PMCID: PMC8547452.

2. Cheung BH, Alisoltani A, Kochan TJ, Lebrun-Corbin M, Nozick SH, Axline CM, Bachta KE, Ozer EA, Hauser AR. Genome-wide screens reveal shared and strain-specific ge¬nes that facilitate enteric colonization by Kleb¬siella pneumoniae. bioRxiv [Preprint]. 2023 Aug 31:2023.08.30.555643. doi: 10.1101/ 2023.08.30.555643. Update in: mBio. 2023 Dec 19; 14(6):e0212823. doi: 10.1128/mbio. 02128-23. PMID: 37693543; PMCID: PMC10 491162.

3. Chuchalin AG, Onishchenko GG, Ko-losov VP, Kurganova OP, Tezikov NL, Manakov LG, Gulevich MP, Perelman YM. Pnevmoniya: regional'nyi opyt organizatsii profilaktiches¬kikh programm [Pneumonia: Regional expe¬rience with prevention programs]. Ter Arkh. 2016;88(8):87-92. Russian. doi: 10.17116/te¬rarkh201688887-92. PMID: 27636932.

4. Freitas AB, Rezende HHA, de Souza GRL, Gonçalves PJ. Photodynamic inactivation of KPC-producing Klebsiella pneumoniae dif¬ficult-to-treat resistance (DTR) by a cationic porphyrin. J Photochem Photobiol B. 2025 Apr;265:113133. doi: 10.1016/j.jphoto¬biol. 2025.113133. Epub 2025 Feb 20. PMID: 39987860.

5. Hazen TH, Adediran T, Hitchcock S, O'Hara LM, Pineles L, Michalski JM, Johnson JK, Nguyen MH, Calfee DP, Miller LG, Harris AD, Rasko DA. Clinical and Bacterial Characte¬ristics Associated with Glove and Gown Conta¬mination by Carbapenem-Resistant Klebsiella pneumoniae in the Health Care Setting. Micro¬biol Spectr. 2023 Aug 17;11(4):e0177523. doi: 10.1128/spectrum.01775-23. Epub 2023 Jun 8. PMID: 37289087; PMCID: PMC1043 4059.

6. Hetland MAK, Winkler MA, Kasper-sen HP, Håkonsholm F, Bakksjø RJ, Bernhoff E, Delgado-Blas JF, Brisse S, Correia A, Foster-vold A, Lam MMC, Lunestad BT, Marathe NP, Raffelsberger N, Samuelsen Ø, Sunde M, Sundsfjord A, Urdahl AM, Wick RR, Löhr IH, Holt KE. A genome-wide One Health study of Klebsiella pneumoniae in Norway reveals overlapping populations but few recent trans¬mission events across reservoirs. Genome Med. 2025 Apr 28; 17(1):42. doi: 10.1186/ s13073-025-01466-0. PMID: 40296028; PMCID: PMC12039103.

7. Holmes CL, Dailey KG, Hullahalli K, Wilcox AE, Mason S, Moricz BS, Unverdorben LV, Balazs GI, Waldor MK, Bachman MA. Pat-terns of Klebsiella pneumoniae bacteremic dissemination from the lung. Nat Commun. 2025 Jan 17;16(1):785. doi: 10.1038/s41467-025-56095-3. PMID: 39824859; PMCID: PMC11742683.

8. Hou Y, Zarodkiewicz P, Cortázar JT, Stoner D, Tulauskas Z, Macori G, Valvano MA, Ingram R, McClean S. Protective efficacy of two novel Klebsiella pneumoniae vaccine an-tigens, LysM/BON and OMPP1, in a murine model. Vaccine. 2025 Nov 14;66:127844. doi: 10.1016/j.vaccine.2025.127844. Epub 2025 Oct 13. PMID: 41086758.

9. Hou Y, Zarodkiewicz P, Cortázar JT, Stoner D, Tulauskas Z, Macori G, Valvano MA, Ingram R, McClean S. Protective efficacy of two novel Klebsiella pneumoniae vaccine an-tigens, LysM/BON and OMPP1, in a murine model. Vaccine. 2025 Nov 14;66:127844. doi: 10.1016/j.vaccine.2025.127844. Epub 2025 Oct 13. PMID: 41086758.

10. Huang J, Alhejaili AY, Alkherd UH, Milner M, Zhou G, Alzahrani D, Banzhaf M, Al-zaidi AA, Rajeh AA, Al-Otaiby MA, Alabbad SS, Bukhari D, Aljurayan AN, Aljasham AT, Alze-yadi ZA, Alajel SM, Hong PY, Alghoribi M, Al-mutairi MM, Pain A, Salem WA, Moradigara-vand D. The dissemination of multidrug-resis¬tant and hypervirulent Klebsiella pneumoniae clones across the Kingdom of Saudi Arabia. Emerg Microbes Infect. 2024 Dec; 13(1): 2427793. doi: 10.1080/22221751.2024.242 7793. Epub 2024 Nov 21. PMID: 39508718; PMCID: PMC11583321.

11. Karampatakis T, Tsergouli K, Lowrie K. Efficacy and safety of ceftazidime-avibac¬tam compared to other antimicrobials for the treatment of infections caused by carbape¬nem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis. Mic¬rob Pathog. 2023 Jun;179:106090. doi: 10.1016/j.micpath.2023.106090. Epub 2023 Mar 31. PMID: 37004964.

12. Kou X, Yang X, Zheng R. Challenges and opportunities of phage therapy for Klebsi¬ella pneumoniae infections. Appl Environ Mic¬robiol. 2024 Oct 23;90(10):e0135324. doi: 10.1128/aem.01353-24. Epub 2024 Sep 30. PMID: 39345202; PMCID: PMC11497816.

13. Lei TY, Liao BB, Yang LR, Wang Y, Chen XB. Hypervirulent and carbapenem-re-sistant Klebsiella pneumoniae: A global public health threat. Microbiol Res. 2024 Nov; 288:127839. doi: 10.1016/j.mic¬res.2024.12 7839. Epub 2024 Aug 11. PMID: 39141971.

14. Li D, Huang X, Rao H, Yu H, Long S, Li Y, Zhang J. Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2023 Apr 20; 13:1157010. doi: 10.3389/fcimb.2023. 1157010. PMID: 37153146; PMCID: PMC1015 9367.

15. Lopatto EDB, Pinkner JS, Sanick DA, Potter RF, Liu LX, Bazán Villicaña J, Tamadon-far KO, Ye Y, Zimmerman MI, Gualberto NC, Dodson KW, Janetka JW, Hunstad DA, Hultgren SJ. Conformational ensembles in Klebsiella pneumoniae FimH impact uropatho¬genesis. Proc Natl Acad Sci U S A. 2024 Sep 24; 121(39):e2409655121. doi: 10.1073/pnas.24 09655121. Epub 2024 Sep 17. PMID: 3928 8182; PMCID: PMC11441496.

16. Russo A, Fusco P, Morrone HL, Tre-carichi EM, Torti C. New advances in manage-ment and treatment of multidrug-resistant Klebsiella pneumoniae. Expert Rev Anti Infect Ther. 2023 Jan; 21(1): 41-55. doi: 10.1080/ 14787210.2023.2151435. Epub 2022 Nov 28. PMID: 36416713.

17. Singh AN, Singh A, Singh SK, Nath G. Klebsiella pneumoniae infections and phage therapy. Indian J Med Microbiol. 2024 Nov-Dec; 52:100736. doi: 10.1016/j.ij¬mmb.2024. 100736. Epub 2024 Oct 5. PMID: 39357832.

18. Urmann E, Stamm P, Wisskirchen J. Cefiderocol bei AML-Patientin mit neutrope-nischem Infekt durch 4MRGN Klebsiella pneu¬moniae (VIM-1) [Cefiderocol in AML patient with neutropenic infection due to 4MRGN Klebsiella pneumoniae (VIM-1)]. Dtsch Med Wochenschr. 2023 Feb;148(4):170-174. Ger¬man. doi: 10.1055/a-1975-2594. Epub 2023 Feb 7. PMID: 36750128.

19. Uzairue LI, Rabaan AA, Adewumi FA, Okolie OJ, Folorunso JB, Bakhrebah MA, Garout M, Alfouzan WA, Halwani MA, Alamri AA, Halawani SA, Alshahrani FS, Hasan A, Mu¬tair AA, Alhumaid S, Etafo J, Utip I, Odoh IM, Uwaezuoke NS. Global Prevalence of Colistin Resistance in Klebsiella pneumoniae from Blo¬odstream Infection: A Systematic Review and Meta-Analysis. Pathogens. 2022 Sep 24; 11 (10):1092. doi:

20. Xu L, Li J, Wu W, Wu X, Ren J. Klebsi-ella pneumoniae capsular polysaccharide: Mechanism in regulation of synthesis, viru-lence, and pathogenicity. Virulence. 2024 Dec; 15(1):2439509. doi: 10.1080/21505594. 2024.2439509. Epub 2024 Dec PMID: 3966 8724; PMCID: PMC11649230.

21. Xu Y, Zhang J, Wang M, Liu M, Liu G, Qu H, Liu J, Deng Z, Sun J, Ou HY, Qu J. Mobili-zation of the nonconjugative virulence plas-mid from hypervirulent Klebsiella pneumo-niae. Genome Med. 2021 Jul 22;13(1):119. doi: 10.1186/s13073-021-00936-5. PMID: 34294 113; PMCID: PMC8299605.

22. Yang P, Liu C, Wu Z, Zheng J, Yi J, Wu N, Wu Z, Lu M, Cui L, Shen N. Klebsiella pneu-moniae infeksiyasiga qarshi davolash qiyin bo'lgan chidamlilik uchun klinik natijalar, mikrobiologik xususiyatlar va xavf omillari. Infeksiya Dori Qarshiligi. 2022 17-ok¬tabr; 15:5959-5969. doi: 10.2147/IDR. S377064. PMID: 36262596; PMCID: PMC9574456.

23. Yu W, Zeng L, Lian X, Jiang L, Xu H, Guo W, Zheng B, Xiao Y. Dynamic cytokine pro¬files of bloodstream infection caused by Kleb¬siella pneumoniae in China. Ann Clin Micro¬biol Antimicrob. 2024 Aug 24;23(1):79. doi: 10.1186/s12941-024-00739-7. PMID: 3918 2143; PMCID: PMC11344948.

24. Zhao M, Li H, Gan D, Wang M, Deng H, Yang QE. Antibacterial effect of phage cock¬tails and phage-antibiotic synergy against pat¬hogenic Klebsiella pneumoniae. mSystems. 2024 Sep 17; 9(9):e0060724. doi: 10.1128/ msystems.00607-24. Epub 2024 Aug 21. PMID: 39166877; PMCID: PMC11406915.

25. Zhong C, Lin S, Li Z, Yang X. Charac-terization of carbapenem-resistant Klebsiella pneumoniae in bloodstream infections: antibi¬otic resistance, virulence, and treatment stra¬tegies. Front Cell Infect Microbiol. 2025 Mar 7; 15:1541704. doi: 10.3389/fcimb.2025.154 1704. PMID: 40125512; PMCID: PMC1192 5884.